Back to search
FDAFDA · Food and drugs·Recall number D-0175-2021

Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270 Don's Lane Conway, AR 72032 (800) 718-3588 NDC 62295-3324-05

Published January 6, 2021 · Recall initiated: November 25, 2020

Summary

FDA records drug Class III recall D-0175-2021, published January 6, 2021 and initiated November 25, 2020. Recalling firm: US Compounding Inc; Status: Terminated; Reported quantity: 1640 syringes; Lot: Lot: 20202109@3 BUD: 3/20/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labelling: Missing label.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
US Compounding Inc
Distributor
Nationwide
Lot
Lot: 20202109@3 BUD: 3/20/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270 Don's Lane Conway, AR 72032 (800) 718-3588 NDC 62295-3324-05 recalled?

Yes. FDA published recall D-0175-2021 on January 6, 2021. Reported hazard: Labelling: Missing label.

What should I do if I have this product?

Voluntary: Firm initiated · Letter